FHTX
Foghorn Therapeutics Inc
NASDAQ: FHTX · HEALTHCARE · BIOTECHNOLOGY
$4.75
-0.21% today
Updated 2026-04-30
Market cap
$311.70M
P/E ratio
—
P/S ratio
10.08x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
Foghorn Therapeutics Inc (FHTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-240.30%
Operating margin
-211.90%
ROE
-470.40%
ROA
-21.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-26.34M | — | — | — |
| 2019 | $0.00 | $-51.13M | — | — | — |
| 2020 | $430000.00 | $-68.80M | -13,322.09% | -15,937.44% | -16,000.00% |
| 2021 | $1.32M | $-101.32M | 100.00% | -7,637.15% | -7,681.58% |
| 2022 | $19.23M | $-108.87M | 99.90% | -609.20% | -566.23% |
| 2023 | $34.16M | $-98.43M | 100.00% | -315.93% | -288.17% |
| 2024 | $22.60M | $-86.62M | 100.00% | -454.31% | -383.24% |
| 2025 | $30.91M | $-74.28M | 89.22% | -265.64% | -240.33% |